Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus + sirolimus versus tacrolimus + mycophenolate mofetil in kidney transplantation
2004-000457-34Phase 3Completed
- Sponsor
- Fujisawa Pharmaceutical
- Start
- Aug 2004
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in end-stage kidney disease (ESKD) comparing Tacrolimus + sirolimus + corticosteroids with Tacrolimus + mycophenolate mofetil + corticosteroids (2 arms). Primary endpoint: Renal function at month 6. Started Aug 2004; status: completed.
02
Drugs
tacrolimussirolimusmycophenolate mofetil
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2004-000457-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000457-34.